– Truveta, a data company dedicated to “Saving Lives with Data,” announced today the launch of the most comprehensive mother-child electronic health record (EHR) dataset ever assembled.

–致力于“用数据拯救生命”的数据公司Truveta今天宣布推出有史以来最全面的母子电子健康记录（EHR）数据集。

– Truveta’s dataset surpasses traditional claims-based datasets, which often lack clinical details and have reporting delays. By offering comprehensive, longitudinal EHR data, Truveta empowers researchers to conduct more rigorous and impactful studies, ultimately improving the lives of mothers and children..

–Truveta的数据集优于传统的基于索赔的数据集，这些数据集通常缺乏临床细节，并且报告延迟。Truveta通过提供全面、纵向的EHR数据，使研究人员能够进行更严格、更有影响力的研究，最终改善母亲和儿童的生活。。

Revolutionizing Research on Mothers and Children

彻底改变对母亲和儿童的研究

Truveta’s dataset offers researchers a unique opportunity to study the complexities of maternal and pediatric health. Key areas of investigation include:

Truveta的数据集为研究人员研究孕产妇和儿科健康的复杂性提供了独特的机会。关键调查领域包括：

Understanding the Link Between Maternal and Neonatal Health: Researchers can explore how maternal health impacts birth outcomes, long-term child development (including neurodevelopment), and childhood conditions up to age 5.Post-Market Drug Safety Monitoring: Truveta’s data can be used to evaluate the safety of medications and vaccines taken by mothers during pregnancy.

了解孕产妇和新生儿健康之间的联系：研究人员可以探索孕产妇健康如何影响出生结局，长期儿童发育（包括神经发育）以及5岁以下的儿童状况。上市后药物安全监测：Truveta的数据可用于评估母亲在怀孕期间服用的药物和疫苗的安全性。

This allows researchers to identify potential risks associated with specific medications and guide future clinical decisions.Studying Category C Medications: Category C medications have potential risks for fetuses, but limited research exists on their effects in humans. Truveta’s data can help determine the safety and efficacy of these medications for pregnant women.Investigating Pediatric Conditions: Researchers can analyze connections between maternal factors (demographics, health history, pregnancy outcomes) and the development of childhood conditions like asthma and eczema..

这使研究人员能够识别与特定药物相关的潜在风险，并指导未来的临床决策。研究C类药物：C类药物对胎儿有潜在风险，但对其对人类影响的研究有限。Truveta的数据可以帮助确定这些药物对孕妇的安全性和有效性。调查儿科疾病：研究人员可以分析母亲因素（人口统计学，健康史，妊娠结局）与哮喘和湿疹等儿童疾病发展之间的联系。。

Unparalleled Data Depth and Security

无与伦比的数据深度和安全性

Truveta’s mother-child dataset offers several key advantages:

Truveta的母子数据集具有几个关键优势：

Comprehensiveness and Timeliness: Truveta leverages data from over 30 healthcare systems, providing a complete picture of patient journeys. This includes clinician notes, medical images, claims data, social determinants of health (SDOH) indicators, and mortality data – all updated daily.Longitudinal Patient Data: With access to over five years of longitudinal data on over 1 million mothers and their children, Truveta offers researchers a rich resource for in-depth analysis.Accuracy and Completeness: Truveta’s data accurately links mothers with their children, preserving crucial details like demographics, medical history, and pregnancy outcomes.

全面性和及时性：Truveta利用来自30多个医疗保健系统的数据，提供患者旅程的完整图片。这包括临床医生笔记、医学图像、索赔数据、健康的社会决定因素（SDOH）指标和死亡率数据，所有这些数据每天都会更新。纵向患者数据：Truveta可以访问超过100万名母亲及其子女的五年纵向数据，为研究人员提供了丰富的深入分析资源。准确性和完整性：Truveta的数据准确地将母亲与孩子联系起来，保留了人口统计学，病史和妊娠结局等关键细节。

Additionally, comprehensive child data is available, including delivery details, diagnoses, procedures, and immunizations up to age 5.Unmatched Privacy and Security: Truveta prioritizes data privacy and security. Their de-identification process adheres to the strictest HIPAA regulations, and they employ robust security protocols to protect patient information..

此外，还提供了全面的儿童数据，包括分娩细节，诊断，程序和5岁以下的免疫接种。无与伦比的隐私和安全性：Truveta优先考虑数据隐私和安全性。他们的身份取消过程遵循最严格的HIPAA法规，并采用强大的安全协议来保护患者信息。。

“Perinatal women and their children have long been excluded from clinical trials and other retrospective data sources, and we can’t understand the full effects of medications, vaccines, and diseases on their connected health outcomes,” said Terry Myerson, CEO and co-founder of Truveta. “Truveta now offers the largest mother-child EHR dataset, empowering researchers to advance care for all mothers and children with complete, timely, and representative data.”.

Truveta首席执行官兼联合创始人Terry Myerson说：“围产期妇女及其子女长期以来一直被排除在临床试验和其他回顾性数据来源之外，我们无法了解药物、疫苗和疾病对其相关健康结果的全面影响。”。“Truveta现在提供了最大的母子EHR数据集，使研究人员能够以完整，及时和有代表性的数据推进对所有母亲和儿童的护理。”